Lexicon Pharmaceuticals LXRX Balance Sheet (2010-2026)

NASDAQ LXRX
$1.86 +0.04 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Lexicon Pharmaceuticals Quarterly Balance Sheet

Periods 66 quarters
Latest Sep 2026

Lexicon Pharmaceuticals reported total assets of $242.02M and total liabilities of $78.18M for the quarter ended Sep 2026, up 17.5% year over year. This balance sheet covers 66 quarters of results from Jun 2010 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
64.07M59.52M21.45M18.83M46.35M26.00M102.27M21.12M22.47M96.49M35.62M34.55M66.66M62.89M21.36M49.66M34.33M38.09M40.92M44.08M
Short-term InvestmentsInvestments (Current)
22.68M26.98M40.52M117.37M92.01M79.94M154.47M197.31M147.56M259.10M274.35M223.82M171.30M131.95M117.64M66.29M61.90M132.57M149.69M139.12M
Cash & Current Investments
86.74M86.50M61.97M136.20M138.36M105.94M256.74M218.43M170.03M355.60M309.96M258.37M237.96M194.84M139.01M115.95M96.23M170.66M190.61M183.20M
Receivables - NetNet Receivables
0.01M0.04M0.03M0.04M0.03M0.26M0.69M0.32M1.01M1.53M2.62M2.90M3.47M47.45M2.18M2.33M2.38M11.78M1.64M1.78M
Receivables
0.01M0.04M0.03M0.04M0.03M0.26M0.69M0.32M1.01M1.53M2.62M2.90M3.47M47.45M2.18M2.33M2.38M11.78M1.64M1.78M
Finished Goods
0.17M
Inventory
0.17M0.34M0.38M0.51M0.59M0.64M0.23M0.20M0.17M0.16M0.28M0.28M1.20M1.21M
Current Assets
88.92M88.43M64.90M139.06M140.87M109.55M263.72M223.37M176.55M364.65M320.84M268.61M246.19M245.81M145.08M122.53M101.90M186.03M196.58M188.84M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
1.18M1.14M1.04M0.93M2.07M2.21M2.20M2.13M1.99M1.84M1.95M2.14M2.48M2.31M2.13M1.98M1.86M1.75M1.65M1.56M
Goodwill
44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M
Intangibles
Goodwill & Intangibles
44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M44.54M
Other Non-Current Assets
2.27M2.06M1.85M7.15M0.41M6.42M6.26M0.74M0.83M0.83M0.83M0.83M0.37M0.37M29.37M29.37M29.37M29.37M0.37M0.37M
Non-Current Assets
47.99M47.75M47.43M52.62M53.43M53.17M53.00M53.11M52.88M52.57M52.51M52.52M52.23M51.87M80.50M83.40M83.09M82.79M53.48M53.18M
Assets
136.91M136.18M112.33M191.69M194.30M162.72M316.72M276.48M229.43M417.22M373.36M321.12M298.42M297.67M225.58M205.93M184.99M268.82M250.06M242.02M
Liabilities
Current Liabilities
Accounts Payables
9.15M9.32M7.35M9.43M10.40M10.31M10.50M12.04M14.39M8.07M12.22M14.20M14.80M10.69M5.90M3.80M3.08M3.00M2.34M4.25M
Payables
9.15M9.32M7.35M9.43M10.40M10.31M10.50M12.04M14.39M8.07M12.22M14.20M14.80M10.69M5.90M3.80M3.08M3.00M2.34M4.25M
Accumulated Expenses
12.97M9.58M9.52M9.02M12.78M10.06M15.61M20.23M17.16M15.33M15.66M21.85M30.45M12.95M11.48M13.62M13.19M6.90M12.36M13.53M
Short term Debt
42.06M4.60M
Current Deferred Revenue
17.46M4.30M
Total Current Liabilities
22.12M18.91M16.86M18.45M23.17M20.37M26.11M32.26M31.55M23.40M27.88M36.05M45.25M110.69M34.84M21.72M20.87M9.90M14.71M17.77M
Non-Current Liabilities
Non-Current Debt
23.48M23.63M23.78M48.58M48.85M98.77M99.27M99.51M99.90M99.50M99.90M100.30M58.64M56.11M56.51M49.41M49.68M51.44M51.89M
Non-Current Deferred Revenue
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Operating Leases
5.42M5.44M5.27M5.08M
Other Non-Current Liabilities
1.19M1.10M1.00M5.44M5.42M5.45M5.48M5.27M6.00M6.67M6.92M5.30M5.20M7.54M7.17M6.38M9.39M8.51M
Total Non-Current Liabilities
22.12M42.38M40.49M42.23M71.75M69.22M124.88M131.05M127.38M135.94M145.55M169.34M90.94M78.23M70.28M59.58M66.14M69.67M
Total Liabilities
23.31M43.48M41.50M47.67M77.18M74.67M130.36M136.97M136.32M128.35M133.38M142.61M152.47M174.64M96.14M85.77M77.45M65.96M75.54M78.18M
Shareholder's Equity
Total Debt
23.48M23.63M23.78M48.58M48.85M98.77M99.27M99.51M99.90M99.50M99.90M100.30M100.70M56.11M56.51M54.00M49.68M51.44M51.89M
Common Equity
113.60M92.70M70.83M144.02M117.12M88.05M186.36M139.51M93.11M288.87M239.98M178.51M145.95M123.03M129.44M120.16M107.54M202.86M174.53M163.85M
Liabilities and Shareholders Equity
136.91M136.18M112.33M191.69M194.30M162.72M316.72M276.48M229.43M417.22M373.36M321.12M298.42M297.67M225.58M205.93M184.99M268.82M250.06M242.02M
Treasury Stock
7.52M2.06M2.06M2.06M2.06M2.89M2.89M2.89M2.89M4.62M4.62M4.62M4.62M5.19M5.19M5.19M5.19M2.84M2.84M2.84M
Retained Earnings
-1,487.78M-1,511.25M-1,535.84M-1,559.23M-1,589.72M-1,621.65M-1,666.56M-1,717.08M-1,766.84M-1,815.24M-1,868.67M-1,933.48M-1,967.24M-1,992.54M-1,989.29M-2,002.05M-2,017.58M-2,018.63M-2,050.40M-2,064.41M
Preferred Shares
0.02M0.00M
Treasury Shares
1.17M0.49M0.49M0.49M0.49M0.87M0.87M0.87M0.87M1.53M1.53M1.53M1.53M2.38M2.38M2.38M2.38M1.93M1.93M1.93M

Lexicon Pharmaceuticals Balance Sheet API

Pull Lexicon Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LXRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY